Received Aug 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | UNK | Y014585 | — |
patient is not experiencing any symptoms/side effects; a VAQTA product was administered to a patient in which a TE assessment had been completed; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 19-JUL-2025, the patient was vaccinated with hepatitis a vaccine, inactivated (VAQTA) suspension for injection at a dose of 0.5 mL, lot #Y014585, expiration date: 01-FEB-2026, for prophylaxis (route of administration and anatomical location were not reported). Before administration, the vaccine underwent temperature excursions (10 min in 50.5 F, 1 hour in -8.5 degrees Celsius); the temperature excursion assessment was completed on 22-JUL-2025 (Product storage error). The patient is not experiencing any symptoms or side effects.